col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


30 Ergebisse       Seite 1

 [1] 
Wiley: Chemistry & Biodiversity
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2026―Mrz―13 Chemical Constituents of Taxodium mucronatum (Cupressaceae) and Some of Its Endophytic Fungi, and Their In Silico and In Vitro Evaluations as SARS-CoV-2 Inhibitors and as Cytotoxic Agents Nadia Mendoza, Olivia Pérez-Valera, Antonio Nieto-Camacho, María Teresa Ramírez-Apan, Marcela Guadalupe Téllez-Martínez, Eleazar M. Escamilla-Silva, Guillermo Delgado
2 [GO] 2025―Dez―13 Computational Insights Into New Portulaca oleracea Alkaloids as Potential SARS-CoV-2 PL pro Inhibitors Mohammad G. Al-Thiabat, Maram B. Alhawarri
3 [GO] 2025―Okt―30 Molecular Roadmap of COVID-19: From Viral Entry to Therapeutic Targets Afeez Adekunle Ishola, Idris Adewale Ahmed, Maryam Abimbola Mikail
4 [GO] 2025―Sep―08 Natural Inhibitors Against Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease From Three Vietnamese Bryophytes Thi-Kim-Dung Le, Gia-Hai Mach, Nguyen-Khanh-Trinh Tram, Nguyen-Kim-Tuyen Pham, Ngoc-Khanh-Van Nguyen, Thi-Minh-Dinh Tran, et al. (+4)
5 [GO] 2025―Aug―29 Bioassay-guided Isolation of SARS-CoV-2 Viral Entry Inhibitors From the Brown Algae Lobophora variegata Identifies Fucoxanthin as a Selective ACE-2/Spike Inhibitor Victoria M. Casimir-Montán, Marie L. Matos-Hernández, Adrián González-Bravo, Edwin A. Hernández-Delgado, Grayce Dyer, Joseph M. Salvino, et al. (+5)
6 [GO] 2025―Aug―26 Therapeutic Uses of Dietary Organosulfur Compounds in Response to Viral (SARS-CoV-2)/Bacterial Infection, Inflammation, Cancer, Oxidative Stress, Cardiovascular Diseases, Obesity, and Diabetes Hiranmoy Barman, Mir Ekbal Kabir, Anupriya Borah, Nazim Uddin Afzal, Rikraj Loying, Bhaben Sharmah, et al. (+3)
7 [GO] 2025―Jul―25 Inhibition Potential of Quercetin Similar Compounds to SARS-CoV-2 Main Protease by High-Throughput Virtual Screening, Molecular Simulations, ADMET Analysis, and DFT Studies Kalpana Gyawali, Sandeep Poudel Chhetri, Kamal Khanal, Mohan Bahadur Kshetri, Rajesh Maharjan, Arjun Acharya, et al. (+3)
8 [GO] 2025―Apr―12 Activity of Sesquiterpene Lactones and Umbelliferone From Campovassouria cruciata on SARS-CoV-2 Replication and on the Release of Pro-Inflammatory Cytokines in Lung Cells Maria Beatriz O. de Rabelo, Kátia M. Freitas, Leonardo C. de Oliveira, Alessandra C. M. Frade, José D. de S. Filho, Gustavo Heiden, et al. (+5)
9 [GO] 2025―Mrz―11 Quantum Chemical and Metabolomic Characterization of Inhibitory Activity of Procyanidins and Flavonol Glucosides from Graptopetalum paraguayense E. Walther against Nonstructural Proteins of SARS-CoV-2 Nadezhda Markova, Nina Stoyanova, Miroslav Rangelov, Nadezhda Todorova, Ivayla Dincheva, Ilian Badjakov, Venelin Enchev
10 [GO] 2025―Jan―24 Amphibian-Derived Peptides as Natural Inhibitors of SARS-CoV-2 Main Protease (Mpro): A Combined In Vitro and In Silico Approach Roque Spinelli, Iván Sanchis, Álvaro Rietmann, María Verónica Húmpola, Alvaro S Siano
11 [GO] 2025―Jan―24 Unveiling the broad spectrum efficacy of volatile terpenes to fight against SARS-COV-2-associated mucormycosis Eman Zahran, Ethar Elfoly, Eyad Y Elhamadany, Muhammad S. Hemied, Tarek A. Elsayed, Mohamed Hisham, Usama Ramadan Abdelmohsen
12 [GO] 2025―Jan―24 Discovery of SARS-CoV-2 Mpro inhibitors through rational design of novel fluorinated 1,3,4-oxadiazole amide derivatives: An in-silico study Huiying Jiang, Heping Xia, Zhonghua Wang, Fei Xiong
13 [GO] 2025―Jan―10 Uncovering Antiviral Potential of Cistus ladanifer Extracts Against HSV-1 and SARS-CoV-2 by In Vitro and In Silico Analysis. Kaoutar Bouothmany, Mohammed Bourhia, Mohammed chebaibi, Zineb Rhazzar, Boutaina Addoum, Farid Khallouki, et al. (+7)
14 [GO] 2024―Dez―13 Screening Asian Medicinal Plants for SARS-CoV-2 Inhibitors: A Computational Approach Hira Khalid, Iqra Ahmad, Asifa Sarfraz, Anwar Iqbal, Umar Nishan, Hanna Dib, et al. (+3)
15 [GO] 2024―Nov―22 Uncovering the Therapeutic Potential of Propolis Extract in Managing Hyperinflammation and Long COVID-19: A Comprehensive Bioinformatics Study Isa Anshori, Donny Marcius, Putri Hawa Syaifie, Khalish Arsy Al Khairy Siregar, Luqman Abdan Syakuran, Muhammad Miftah Jauhar, et al. (+3)
16 [GO] 2024―Okt―23 Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New Thiazolidinone Derivatives as NNRTIs and SARS-CoV-2 Main Protease Inhibitors Maria Fesatidou, Anthi Petrou, Athina Geronikaki
17 [GO] 2024―Aug―20 DFT, Molecular Docking, ADME, and Cardiotoxicity Studies of Persuasive Thiazoles as Potential Inhibitors of the Main Protease of SARS-CoV-2 Muhammad Asim Khan, Sadaf Mutahir, Gauhar Jabar, Zhao Wenwei, Muhammad Atif Tariq, Abdulrahman A. Almehizia, Muhammad Mustafa
18 [GO] 2024―Aug―07 Discovery of a Highly Promising Disulfide Derivative Scaffold as Inhibitor of SARS-CoV-2 main protease Yin-Sui Xu, Yang Xiang, Le Zhai, Cheng Chen, Xiao-Rong Wu, Wei-Ya Chen, et al. (+4)
19 [GO] 2024―Jul―08 Investigating the Potential of 2-Ethylbutyl-(Phenoxy)phosphoryl-D-Alaninate Against RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 Sandeep Yadav, Durgesh Kumar, Haritma Chopra, Ishita Bhatt, Ritu Gabba, Ankita Chaudhary, PRASHANT SINGH
20 [GO] 2024―Jun―05 Olive Leaf Extract Downregulates the Protein Expression of Key SARS-CoV-2 Entry Enzyme ACE-2, TMPRSS2, and Furin Abdurrahim Kocyigit, Ebru Kanimdan, Vildan Betul Yenigun, Zeynep Ozman, Fatmanur Babalı Balıbey, Ezgi Durmuş, Oznur Yasar
21 [GO] 2024―Mrz―25 Exploring the Efficacy of Noncovalent SARS-CoV-2 Main Protease Inhibitors: A Computational Study Incorporating Design, ADMET, Molecular Dynamics Simulation, and DFT Analysis Fei Xiong, Yan-Jun Zhang, Hui-Ying Jiang, Zhong-Hua Wang
22 [GO] 2024―Mrz―11 In Silico and In Vitro Screening of Some Pregnane Glycosides Isolated from Certain Caralluma Species as SARS-COV-2 Main Protease Inhibitors Essam Abdel-Sattar, Omnia Kutkat, Riham A. El-Shiekh, Mohamed K. El-Ashrey, Ahmed M. El Kerdawy
23 [GO] 2023―Nov―15 Molecular Design of Novel Inhibitor by TargetingIL-6Rα using Combined Pharmacophore and Experimentally Verified Plant Products with Scaffold-Hopping Techniques: A Dual Therapeutic Strategy for COVID-19 and Cancer Ishani Paul, Alankar Roy, Sujay Ray
24 [GO] 2023―Okt―27 Discovery of SARS-CoV-2 Inhibitors Featuring Novel Histidine α-Nitrile Motif Nilu V. Gone, M. Ghalib Enayathullah, Jessie Thomas, Parth Rathee, Rajeev Prabhakar, Kiran K. Bokara, Gangadhar J. Sanjayan
25 [GO] 2023―Okt―20 The Discovery of Novel Small Oxindole-based Inhibitors Targeting the SARS-CoV-2 Main Protease (Mpro) Lara Alzyoud, Radwa E. Mahgoub, Feda E. Mohamed, Bassam R. Ali, Juliana Ferreira, Wael M. Rabeh, et al. (+2)
26 [GO] 2023―Feb―06 Studies of cytotoxicity effects, SARS-CoV-2 main protease inhibition, and in silico interactions of synthetic chalcones. Octavio L. Guterres Fernandes, Tiago Tizziani, Bibiana P. Dambrós, Natália Ferreira de Sousa, Carime L. Mansur Pontes, Layzon A. L. da Silva, et al. (+7)
27 [GO] 2023―Jan―04 A drug repurposing approach to identify therapeutics by screening pathogen box exploiting SARS-CoV-2 main protease Rashmi Tyagi, Anubrat Paul, Krishna Kumar Ojha, V Samuel Raj, Aditya K Panda, Sunil Kumar, et al. (+2)
28 [GO] 2022―Sep―20 The Efficacy of Traditional Medicinal Plants in Modulating the Main Protease of SARS-CoV-2 and Cytokine Storm Jomin Choe, Phaik Har Yong, Zhi Xiang Ng
29 [GO] 2022―Feb―25 Isolation of thioinosine and butanolides from a Terrestrial Actinomycetes sp. GSCW-51 and their in-silico Studies for Potential against SARS-CoV-2 Muhammad Imran Tousif, Mamona Nazir, Muhammad Khalid, Shehla Perveen, Naseem Akhtar, Nosheen Farooq, et al. (+5)
30 [GO] 2021―Nov―23 Computational prediction of the potential target of SARS-CoV-2 inhibitor plitidepsin via molecular docking, dynamic simulations and MM-PBSA calculations Mahmoud El Hassab, Loah Hemeda, Zainab Elsayed, Sara Al-Rashood, Mohammed Amin, Hatem Abdel-Azizf, Wagdy Eldehna
 [1] 

30 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec